Therapeutic Vaccine With Novel Checkpoint Inhibition - Sue Currie, Phd

Therapeutic Vaccine with Novel Checkpoint Inhibition - Sue Currie, PhD

Academic Medical Education

FOXC1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy

Immunomatrix: A Novel Vaccine Delivery Paradigm | Katarzyna Sawicka | TEDxSBU

Dr. Beachler on HPV Vaccine Efficacy Among Previously Exposed Individuals

COVID-19 Vaccines for patients treated for Lung Cancer with Immune checkpoint inhibitors

Medical Dialogues

Investigating Therapeutic Vaccines

Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis

British Pharmacological Society

Dendritic cell vaccine for MM: Trial updates with maintenance & checkpoint inhibitor pidilizumab

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Hammers on Combination of Vaccines and Immune Checkpoint Inhibitors in RCC

Developing novel therapeutic strategies to target DNA damage response

COVID 19 Vaccine and Immune Checkpoint Inhibitors

SDSHP Clinical Pearls For Pharmacists

Impact of antibiotic use on checkpoint inhibitor efficacy

Therapeutic HPV Vaccine Clinical Trial - Vaccine Design

UAMS

Michelle Teplensky on Rational Vaccinology

International Institute for Nanotechnology

Emerging Checkpoint Inhibitors for HNSCC

Rational Vaccine Strategies by Dennis Burton, PhD

Scripps Research

Ask a Professor ft. Paul Duprex, PhD | Vaccine Research at Pitt

University of Pittsburgh

Novel Targets: PIKfyve, RAS, the epigenome & PROTAC therapy

VJHemOnc – Video Journal of Hematology & HemOnc

DNA damage repair pathways and WEE1 as possible therapeutic targets in SCLC

COVID-19 Vaccinations | Get the Facts: Dr. Susan Huang Debunks Vaccine Fertility Myths (English)